229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
30.31%
Positive growth while VUZI shows revenue decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
30.31%
Positive growth while VUZI shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Operating expenses growth while VUZI reduces costs. John Neff would investigate differences.
100.00%
Total costs growth while VUZI reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
139.22%
EBITDA growth exceeding 1.5x VUZI's 13.77%. David Dodd would verify competitive advantages.
130.10%
EBITDA margin growth while VUZI declines. John Neff would investigate advantages.
139.22%
Operating income growth exceeding 1.5x VUZI's 10.47%. David Dodd would verify competitive advantages.
130.10%
Operating margin growth while VUZI declines. John Neff would investigate advantages.
117.04%
Other expenses growth above 1.5x VUZI's 38.20%. Michael Burry would check for concerning trends.
139.22%
Pre-tax income growth exceeding 1.5x VUZI's 11.25%. David Dodd would verify competitive advantages.
130.10%
Pre-tax margin growth while VUZI declines. John Neff would investigate advantages.
139.22%
Tax expense change of 139.22% while VUZI maintains burden. Bruce Berkowitz would investigate strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.12%
Share count reduction while VUZI shows 0.33% change. Joel Greenblatt would examine strategy.
-0.12%
Diluted share reduction while VUZI shows 0.33% change. Joel Greenblatt would examine strategy.